gip/glp-1 agonist Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an GLP-1 Receptor Agonists – Peripheral
Description
Tirzepatide (Subcutaneous Route)
Thus, the clinically therapeutic strategy for T2DM should not only effectively control the patients glucose levels, but also minimize the complications of bone metabolism diseases
GLP-1RAs, which achieved great success in 2023 and draws peoples attention back to obesity treatments and GLP-1 therapies worldwide, was chosen as the breakthrough of year 2023 by Science [2]
doi: 10.2337/dc19-0749 [DOI] [PubMed] [Google Scholar] 222
Is GLP-1 hair loss the same as male or female pattern baldness
Wang X-C, Gusdon AM, Liu H, Qu S
